文献速递肝胆胰外科围术期管理与 ERAS

新型胆漏试验:对比增强术中超声胆管造影在肝切除中的应用

A novel bile leak test using contrast-enhanced intraoperative ultrasonic cholangiography in liver resection: a prospective single-arm trial.
PubMed 文献 · Surg Endosc · 2026-07-08

前瞻性单臂试验纳入29例开放肝切除患者,经胆囊管导管注入Sonazoid、靛胭脂与盐水混合试剂,夹闭远端胆总管,用对比谐波超声评估切面附近胆管充盈。技术成功率86.2%,术后胆漏5例(17.2%),无注射相关不良事件,术后AST/ALT升高较历史对照显著降低但为探索性比较。

要点

  • CE-IOUSC胆漏试验在开放肝切除中技术可行且安全。
  • 可实时确认切面附近胆管内试剂充盈,术中检出胆漏3例并缝合。
  • 术后胆漏率17.2%,降低胆漏或肝损伤的临床疗效尚未证实。

核心结论

  • 基于CE-IOUSC的胆漏试验在开放肝切除中可行且安全,能实时确认切面附近胆管内试剂充盈。
  • 其降低术后胆漏或肝损伤的临床疗效尚未证实,需未来对照研究评估。

研究设计与样本

  • 前瞻性单臂试验,2021年3月至2024年2月纳入29例按最终方案行开放肝切除的患者。

主要发现

  • CE-IOUSC试验技术成功25/29例(86.2%)。
  • 中位总注射量5 mL(范围2-22 mL),中位分割注射次数2次(范围1-6次)。
  • 术中检出胆漏并缝合3例。
  • 术后胆漏5例(17.2%):技术成功4例,技术失败1例。
  • 未观察到胆管内试剂注射相关不良事件。

临床怎么用

  • 可在开放肝切除中经胆囊管注入稀释Sonazoid、靛胭脂与盐水混合试剂,夹闭远端胆总管后用对比谐波超声实时评估切面附近胆管充盈。
  • 术中检出胆漏可即时缝合处理。
  • 该技术降低术后胆漏或肝损伤的疗效未证实,不应替代现有标准胆漏检测。

局限性

  • 单臂设计,无同期对照,疗效结论受限。
  • 与历史队列的肝酶比较为探索性。
  • 样本量29例,技术失败4例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bile leak (BL) remains a major complication after liver resection and is associated with substantial postoperative morbidity. Conventional dye-based tests can identify visible leakage from the transection surface, but whether the injected reagent has adequately reached peripheral intrahepatic ducts adjacent to the cut surface is often uncertain. We evaluated the feasibility and safety of a novel BL test using contrast-enhanced intraoperative ultrasonic cholangiography (CE-IOUSC) for real-time confirmation of intrabiliary reagent filling. METHODS: This prospective single-arm trial included 29 patients undergoing open liver resection under the finalized protocol between March 2021 and February 2024. A reagent consisting of diluted Sonazoid, indigo carmine, and saline was injected through a cystic-duct catheter while the distal common bile duct was clamped. Ductal filling near the transection plane was assessed using contrast harmonic ultrasonography during and immediately after manual divided injection. Outcomes included technical success, postoperative BL, injection-related adverse events, and exploratory comparison of postoperative liver enzymes with a historical conventional-test cohort. RESULTS: CE-IOUSC testing was technically successful in 25 of 29 patients (86.2%). The median total injected volume was 5 mL (range 2-22 mL), and the median number of divided injections was 2 (range 1-6). Intraoperative BL was detected and sutured in 3 patients. Postoperative BL occurred in 5 patients (17.2%): 4 after technical success and 1 after technical failure. No adverse events related to intrabiliary reagent injection were observed. Postoperative AST and ALT elevations were significantly lower than in the historical cohort, although this comparison was exploratory. CONCLUSIONS: CE-IOUSC-based BL testing was feasible and safe in open liver resection and enabled real-time confirmation of intrabiliary reagent filling near the transection surface. Its clinical efficacy in reducing postoperative BL or liver injury remains unproven and should be evaluated in future comparative studies.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Urade T, Shimura Y, Kido M, et al. A novel bile leak test using contrast-enhanced intraoperative ultrasonic cholangiography in liver resection: a prospective single-arm trial. Surg Endosc. 2026. PMID: 42420496. doi:10.1007/s00464-026-13092-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。